BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 4014326)

  • 1. Rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis during treatment with high-dosage D-penicillamine.
    Sadjadi SA; Seelig MS; Berger AR; Milstoc M
    Am J Nephrol; 1985; 5(3):212-6. PubMed ID: 4014326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penicillamine-induced rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis.
    Almirall J; Alcorta I; Botey A; Revert L
    Am J Nephrol; 1993; 13(4):286-8. PubMed ID: 8267029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracapillary glomerulonephritis with necrotizing vasculitis in D-penicillamine-treated rheumatoid arthritis.
    Banfi G; Imbasciati E; Guerra L; Mihatsch MJ; Ponticelli C
    Nephron; 1983; 33(1):56-60. PubMed ID: 6339966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Glomerulopathy due to D-penicillamine--clinical findings and renal biopsy].
    Brass H; Genth E; Hartl PW; Bauerdick H; Buss H; Lapp H; Heintz R
    Med Welt; 1976 Nov; 27(45):2151-3. PubMed ID: 994834
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapidly progressive glomerulonephritis with D-penicillamine.
    Nanke Y; Akama H; Terai C; Kamatani N
    Am J Med Sci; 2000 Dec; 320(6):398-402. PubMed ID: 11149553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-penicillamine-induced crescentic glomerulonephritis and antimyeloperoxidase antibodies in a patient with scleroderma. Case report and review of the literature.
    Karpinski J; Jothy S; Radoux V; Levy M; Baran D
    Am J Nephrol; 1997; 17(6):528-32. PubMed ID: 9426850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-penicillamine induced crescentic glomerulonephritis: report and review of the literature.
    Devogelaer JP; Pirson Y; Vandenbroucke JM; Cosyns JP; Brichard S; Nagant de Deuxchaisnes C
    J Rheumatol; 1987 Oct; 14(5):1036-41. PubMed ID: 3430507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [MPO-ANCA positive rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis during treatment with D-penicillamine].
    Nanke Y; Akama H; Terai C; Hara M; Kamatani N
    Nihon Rinsho Meneki Gakkai Kaishi; 1999 Oct; 22(5):354-9. PubMed ID: 10616290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-penicillamine therapy associated with rapidly progressive glomerulonephritis.
    Macarrón P; García Díaz JE; Azofra JA; Martín de Francisco J; Gonzalez E; Fernandez G; Sampedro J
    Nephrol Dial Transplant; 1992; 7(2):161-4. PubMed ID: 1314978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Membranous glomerulonephritis caused by D-penicillamine].
    Bécares Lozano MM; Pascual Izuel JM; Mateos Sánchez A; Delgado Martínez J; Querol Prieto R; Flores Corral T
    Rev Clin Esp; 1982 Mar; 164(6):411-2. PubMed ID: 7111809
    [No Abstract]   [Full Text] [Related]  

  • 11. D-Penicillamine-induced ANCA-associated crescentic glomerulonephritis in Wilson disease.
    Bienaimé F; Clerbaux G; Plaisier E; Mougenot B; Ronco P; Rougier JP
    Am J Kidney Dis; 2007 Nov; 50(5):821-5. PubMed ID: 17954295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penicillamine-induced rapidly progressive glomerulonephritis in patients with progressive systemic sclerosis: successful treatment of two patients and a review of the literature.
    Ntoso KA; Tomaszewski JE; Jimenez SA; Neilson EG
    Am J Kidney Dis; 1986 Sep; 8(3):159-63. PubMed ID: 3752071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1 inhibitor deficiency in a patient with rheumatoid arthritis--increased risk of adverse effects of penicillamine?
    Sturfelt G; Rydgren L; Truedsson L; Alm P; Sjöholm AG
    J Rheumatol; 1996 Feb; 23(2):378-81. PubMed ID: 8882051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive proliferative glomerulonephritis in a patient with rheumatoid arthritis treated with D-penicillamine.
    Williams AJ; Fordham JN; Barnes CG; Goodwin FJ
    Ann Rheum Dis; 1986 Jan; 45(1):82-4. PubMed ID: 3954462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [D-penicillamine and glomerulonephritis].
    Altrogge G; Hofmann K; Huth F; Grabensee B; Schoppe WD
    Med Welt; 1976 Nov; 27(47):2282-3. PubMed ID: 1004174
    [No Abstract]   [Full Text] [Related]  

  • 16. [Morphology and pathogenesis of penicillamine-induced nephropathy].
    Henzgen S; Waldmann G
    Zentralbl Allg Pathol; 1983; 128(1-2):53-61. PubMed ID: 6637187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Extramembranous glomerulonephritis induced by D-penicillamine. Description of a case].
    Miguel Donderis A; Sánchez Vegazo I; Gómez Campdera FJ; Gallego JL; Fernández Fernández J; Sanz Guajardo D; Botella J
    Rev Clin Esp; 1981 Jan; 160(2):137-8. PubMed ID: 7209061
    [No Abstract]   [Full Text] [Related]  

  • 18. Fatal renal vasculitis and minimal change glomerulonephritis complicating treatment with penicillamine. Report on two cases.
    Falck HM; Törnroth T; Kock B; Wegelius O
    Acta Med Scand; 1979; 205(1-2):133-8. PubMed ID: 760401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glomerulopathy in rheumatic patients due to penicillamine].
    Muller V; Krumhaar I; Schneider W; Ditscherlein G
    Allerg Immunol (Leipz); 1976; 22(3):291-5. PubMed ID: 139094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membranous glomerulonephritis in rheumatoid arthritis not related to gold or D-penicillamine therapy: a report of four cases and review of the literature.
    Honkanen E; Törnroth T; Pettersson E; Skrifvars B
    Clin Nephrol; 1987 Feb; 27(2):87-93. PubMed ID: 3829481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.